Structural valvular deterioration of Hancock standard valve in the mitral position 33 years after initial implantation.

A 77-year-old woman who had undergone mitral valve replacement (MVR) with a 29 mm Hancock standard (H-S) bioprosthesis (Model 242) and tricuspid annuloplasty (Kay's method) at the age of 44 years was admitted urgently with acute heart failure. Echocardiography showed severe transvalvular leakage of the prosthesis and moderate tricuspid regurgitation. The patient underwent reMVR with a 29 mm Carpentier-Edwards Perimount Magna Mitral bioprosthesis and tricuspid annuloplasty with a 30 mm MC3 ring. The explanted bioprosthesis showed mild calcification and a tear in the leaflet, dehisced commissures and pannus overgrowth. To our knowledge there are no reports describing H-S valves that were still functioning over 30 years after implantation. Herein, we report a case of reMVR in a patient with an H-S valve that had been implanted 33 years previously.

A Safety and Efficacy Study of Tolvaptan Following Open Heart Surgery in 109 Cases.

This study was conducted to evaluate the safety and efficacy of tolvaptan following open heart surgery.We retrospectively reviewed 109 patients who were administered tolvaptan following open heart surgery between August 2011 and July 2014. We divided the patients according to their urine output index (amount of urine output/body surface area) into tertiles as follows: T1 (low responders; n = 36), T2 (intermediate responders; n = 36), and T3 (high responders; n = 37). No fatal adverse events were observed following tolvaptan administration. The factors that showed a significant difference among the 3 groups were body surface area (BSA) and preoperative body weight. Body weight rapidly decreased and a greater increase in the serum sodium level was observed on day 1 in the T3 group than in the other 2 groups. No decrease in blood pressure and no significant differences in the occurrence of atrial fibrillation were observed among the 3 groups during tolvaptan administration.Tolvaptan can be safely and effectively administered to increase the urine output without adversely affecting the cardiovascular system or renal function following open heart surgery. However, careful attention is required regarding the possibility of a rapid increase in the serum sodium level so it is important to monitor changes in serum Na levels.

Atrial Functional Tricuspid Regurgitation Associated With Atrial Standstill.

We report a case of atrial functional tricuspid regurgitation with an atrial standstill in a 71-year-old woman with a history of chronic atrial fibrillation (AF). The ECG showed a flat baseline with no AF waves and regular, narrow QRS complexes, whereas the previous ECG demonstrated AF. Echocardiography revealed dilation of the right atrium and the tricuspid annulus with severe regurgitation, but mitral regurgitation was mild. No atrial contraction was detected. Bilateral ventricular function was preserved. Cardiac catheterization showed no pulmonary hypertension and an a-wave in atrial pressure tracings. During surgery, epicardial pacing was unable to capture both atria. The tricuspid valve was replaced and a pacemaker was implanted.

Ventricular energetics early after surgery for chronic mitral regurgitation: repair versus replacement.

BACKGROUND AND AIM OF THE STUDY: The study aim was to compare the effects of mitral valve (MV) repair and replacement with partial (posterior leaflet only) chordal preservation on left ventricular (LV) performance in chronic degenerative mitral regurgitation (MR) by assessing ventricular energetics. METHODS: Contractility (end-systolic elastance), afterload (effective arterial elastance), and ventricular efficiency (ventriculoarterial coupling and the ratio of stroke work to pressure-volume area were determined using transthoracic echocardiography data obtained before and at one month after surgery in 29 patients undergoing MV repair, and in 12 patients undergoing partial chordal-sparing MV replacement. A two-way analysis of variance with repeated measures was used for comparisons among patients who underwent MV surgery (valve repair versus valve replacement). RESULTS: The LV diastolic volume index was decreased significantly in both groups (p<0.0001), whereas the LV systolic volume index did not change significantly (p=0.956). Despite the similar remarkable decrease in ejection fraction (p<0.0001) in both groups, end-systolic elastance remained unchanged (p=0.312). Effective arterial elastance was increased significantly in both groups (p<0.0001). Ventriculoarterial coupling and the ratio of stroke work to pressure-volume area deteriorated similarly in both groups (p<0.0001 and p<0.0001). CONCLUSION: Compensation of LV geometry after correction of chronic MR preserved ventricular contractility. Furthermore, the results of MV repair were not superior to those of MV replacement with partial chordal preservation in the early postoperative period. This suggested that partial chordal-sparing MV replacement is an effective method for the treatment of chronic MR in selected patients.

Right Coronary Artery with an Intramural and Interarterial Course as a Unique Cause of Myocardial Ischemia: The Unroofing Method Might Still Be the Best Solution.

A 39-year-old man was admitted because of cardiac arrest. Emergent coronary angiography revealed a preserved coronary blood flow; however, multiple-row detector computed tomography (MDCT) revealed that the proximal right coronary artery (RCA) was running inside the aortic wall, creating proximal stenosis without atherosclerotic changes. Surgical intervention with unroofing was performed; however, postoperative stenosis of the proximal RCA required additional coronary artery bypass grafting (CABG). Intraoperative findings during CABG did not reveal hematoma or coronary dissection. However, MDCT one year after CABG depicted improvement of the RCA and graft stenoses, suggesting that the post-unroof stenosis may have been caused by an inflammatory reaction after surgical intervention.

Gum chewing enhances early recovery of bowel function following transperitoneal abdominal aortic surgery.

BACKGROUND AND PURPOSE: Postoperative bowel dysfunction is still a major unsolved problem following transperitoneal abdominal aortic surgery. We conducted this study to establish if gum chewing during the postoperative period promotes recovery of bowel function following abdominal aortic surgery. METHODS: The subjects were 44 patients who underwent elective abdominal aortic surgery. The patients were allocated to a control group (n = 21), who received standard postoperative care, or a "gum group" (n = 23), who received standard postoperative care and were also given gum to chew three times a day from postoperative day (POD) 0-5. RESULTS: The patient characteristics, intraoperative, and postoperative care were equivalent in both groups. Flatus was passed on POD 1.49 in the gum group and on POD 2.35 in the control group (P = .0004) and the time to oral intake was 3.09 days in the gum group and 3.86 days in the control group (P = .023). The number of days to full mobilization in the hospital room was 3.35 versus 5.59 for the gum and control groups, respectively (P < .0001). CONCLUSIONS: Gum chewing enhances early recovery of bowel function following transperitoneal abdominal aortic surgery. Moreover, it is a physiologically sound, safe, and an inexpensive part of the postoperative care.

Twelve-year experience with the Carpentier-Edwards pericardial aortic valve at a single Japanese center.

Our aim was to evaluate the long-term results of implantation of the Carpentier-Edwards pericardial (CEP) valve in the aortic position. Between January 1996 and December 2007, 244 patients who underwent aortic valve replacement using the CEP valve were enrolled in this study. A 19-mm valve was used in 39 patients, a 21-mm valve in 94 patients, a 23-mm valve in 81 patients, and a 25-mm valve in 30 patients. The early and the late results were evaluated. Furthermore, echocardiographic examination was performed at follow-up. There were 5 early deaths, with an early mortality rate of 2.0%. Follow-up was performed in 95.4% of the survivors of the operation for a mean period of 4.1 years. Actuarial survival rates at 5, 10, and 12 years were 85.3 ± 2.8, 80.0 ± 3.7 and 70.0 ± 9.8%, respectively. Thromboembolism was observed in 6 patients, endocarditis in 2 patients, reoperation in 4 patients, and structural valve deterioration in 2 patients. Actuarial freedoms from thromboembolism, endocarditis, and reoperation at 10 years were 96.9 ± 0.14, 97.7 ± 0.16, and 97.0 ± 0.16%, respectively. Echocardiographic examination revealed that the pressure gradients across the valve prosthesis for valves of each size were acceptable. Left ventricular mass index decreased significantly in all valve sizes. The long-term results of implantation of the CEP bioprosthesis in the aortic position were satisfactory. The CEP bioprosthesis maintained its hemodynamic performance even as late as 10 years after implantation.

Edge-to-edge repair for mitral regurgitation: a clinical and exercise echocardiographic study.

BACKGROUND AND AIM OF THE STUDY: The durability and potential for creating functional mitral stenoses are major concerns in the edge-to-edge (E-to-E) repair of mitral regurgitation (MR). METHODS: Valve repair for MR was performed using the classical Carpentier technique in 120 patients (group C), and with the E-to-E technique in 37 patients (group E). A ring annuloplasty was performed in all patients. The mid-term results were examined and exercise echocardiography was conducted. RESULTS: No significant differences were observed between the two groups with regards to early and late mortality rates, actuarial survival rate and valve-related complication-free rate at five years after surgery. Postoperatively, MR was decreased significantly in both groups. Exercise echocardiography was undertaken in 35 operative survivors (20 from group C, 15 from group E). At peak exercise, the mean transmitral pressure gradient (MTPG) increased significantly in both groups. Systolic pulmonary artery pressure (SPAP) was also significantly elevated, but still within the accepted upper limits in both groups. The mitral valve area (MVA) showed no significant increase in either group. At peak exercise there were no significant differences in MTPG, SPAP and MVA between the two groups. CONCLUSION: Edge-to-edge repair is equally effective and durable as a conventional repair using the Carpentier technique. A mitral valve redesigned by E-to-E repair with ring annuloplasty may be slightly restrictive compared to a normal healthy mitral valve under exercise conditions; however, the hemodynamic performance did not differ significantly from that of a valve repaired with the Carpentier technique. These hemodynamics were not related to the use of E-to-E repair per se as the only causal factor, but rather to the ring annuloplasty.

Mid-term results of valve replacement with the ATS valve: a seven-year follow up.

BACKGROUND AND AIM OF THE STUDY: The ATS open pivot bileaflet valve has been the prosthesis of choice at the authors' hospital since 1997. Herein is presented a retrospective analysis of the mid-term results of valve replacement with the ATS valve prosthesis. METHODS: Between 1997 and 2005, a total of 280 patients (mean age 58.3 years) underwent valve replacement with the ATS valve; these included 133 aortic valve replacements (AVR), 115 mitral valve replacements (MVR), and 32 double (aortic plus mitral) valve replacements (DVR). Preoperatively, 162 patients (57.9%) were in NYHA functional class II, 97 (34.6%) in class III, 19 (6.8%) in class IV, and two (0.7%) in class V. Atrial fibrillation was detected in 105 patients (37.5%), and significant coronary artery disease was found concomitantly in 13 (4.6%). Postoperative anticoagulant therapy consisting of warfarin and an antiplatelet drug was usually instituted on the first postoperative day, and the International Normalized Ratio maintained between 1.6 and 2.5. RESULTS: Overall hospital mortality was 3.6% (n = 10). Hospital survivors were followed for a mean period of 4.2 years (maximum 10 years); the total follow up was 1,127.9 patient-years (pt-yr). Follow up was complete for 267 patients (98.9%). Actuarial survival at seven years was 87.1% for AVR, 79.8% for MVR, and 90.1% for DVR. The probability of freedom from valve-related death at seven years was 96.7% for AVR, 94.4% for MVR, and 100% for DVR. The linearized rates for postoperative complications were thromboembolism 1.2%/pt-yr, major bleeding 0.7%/pt-yr, prosthetic valve endocarditis 0.2%/pt-yr, non-structural dysfunction 0.7%/pt-yr, and reoperation 0.5%/pt-yr. Structural valve failure was not encountered. CONCLUSION: This clinical experience with the ATS open pivot heart valve demonstrated low rates of adverse events and valve-related complications.

A case of fulminant myocarditis treated with very long-term support by cardiopulmonary support system.

Fulminant myocarditis (FM) sometimes causes severe left ventricular dysfunction and lethal arrhythmias leading to cardiogenic shock and critical conditions. Thus, mechanical circulation support with intra-aortic balloon pumping and/or a cardiopulmonary support system (CPS) is sometimes needed to save lives. The special recommended therapies for FM for that classified as class I (evidence level C) in the guidelines of the Japanese Circulation Society are intra-aortic balloon pumping, CPS, percutaneous cardiac pacing, and a left ventricular assist device (LVAD), and they are well established in evidence-based medicine. We experienced a case of FM that we were able to save by long-term stable CPS support. Because, unfortunately, the LVAD was not commercially available in Japan at that time, intensive treatments including CPS were continued in our hospital. Finally, a good course of the illness was achieved without any adverse complications. Thus, these intensive treatments in the present case may be one of the optional effective strategies for FM, especially in hospitals and/or countries where the LVAD is not (commercially) available, and when an LVAD may not be suitable because of complications associated with infectious disease. .

Infective endocarditis during pregnancy: report of a case.

A 23-year-old woman, gravida 1, para, 0, was transferred at 29 weeks and 2 days gestation for management of infective endocarditis (IE). Based on vegetations attached to the mitral valve by echocardiography and positive blood cultures for Streptococcus mitis, the diagnosis of IE was made at the referring hospital. On admission to our hospital, echocardiography demonstrated a large vegetation and prolapse of the mitral valve with severe valve regurgitation. The fetal heart rate was 140/min. Ultrasound examination demonstrated an appropriate for gestational age 1,350 g fetus in vertex presentation. The day after admission, her membrane ruptured spontaneously, and she delivered a male infant by caesarean section at 29 weeks and 3 days of gestation. On the 42nd day of hospitalization, the mitral valve was reconstructed by quadrangular resection of the posterior commissure and annuloplasy with a prosthetic ring. A histological examination of specimens of the resected leaflets indicated that IE was active. One year later, the patient delivered a healthy infant without any complications by a caesarean section. The latest Doppler study demonstrated trivial mitral regurgitation and a mitral valve area of 2.5 cm2.

Usefulness of 18F-FDG-PET/CT in aortic graft infection: two cases.

Diagnosis of vascular graft prosthesis infection is crucial, but not straightforward. Here we report two cases in which [(18)F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) was very useful in the diagnosis of aortic graft infection. Case 1: A 77-year-old Japanese man, two months status post aortic arch graft surgery, suffered from repeated fevers. Blood cultures revealed bacteremia. (18)F-FDG-PET/CT ruled out graft infection and diagnosed lumbar pyogenic spondylitis, which was treated with antibiotics, sparing the patient a possible reoperation. Case 2: A 53-year-old Japanese man, seven years status post replacement of the aortic root and ascending aorta, had been suffering from an ostensibly aseptic fistula for over a year and a half. Although repeated CT findings had been negative, (18)F-FDG-PET/CT clearly demonstrated communication between the fistula and the ascending aortic graft. He was treated with repeat ascending aortic replacement, omentopexy, and antibiotics. Our experience supports (18)F-FDG-PET/CT as a promising modality in cases of suspected vascular graft infection.

Left ventricular-right atrial communication following tricuspid annuloplasty.

A 71-year-old woman was admitted for examination of a heart murmur and anemia. She had a history of mitral valve replacement and tricuspid ring annuloplasty 8 months prior to admission. A new systolic murmur was heard, and echocardiography showed a high-velocity jet originating from the left ventricular outflow tract to the right atrium and a small defect between the left ventricle and the right atrium. No periprosthetic leaks were detected in the mitral position. At operation, a communication just beneath the detached prosthetic ring at the anterior-septal commissure of the tricuspid valve, and a jet of bright red blood entering the right atrium through the defect at the atrial septum just cephalad to the commissure, were found. After removing the ring, the defect was closed using a mattress suture. In this case, the tricuspid annuloplasty ring was probably placed on the atrio-ventricular portion of the membranous septum, rather than the tricuspid annulus, at the antero-septal commissure of the tricuspid valve in the previous operation, and its dehiscence may have created a tear in the atrio-ventricular membranous septum, leading to left ventricular-right atrial communication.

Long-term results of aortic valve replacement with a small St. Jude medical valve in Japanese patients.

BACKGROUND: The use of small aortic valve prostheses is still controversial because of negative effects caused by residual obstruction of the left ventricular outflow tract. This study evaluated the long-term results after aortic valve replacement with a small valve from St. Jude Medical (St. Paul, MN). METHODS: Between 1980 and 1999, 221 patients underwent isolated aortic valve replacement with a 23-mm or smaller St. Jude Medical valve. The mortality rate and complications were analyzed, echocardiography was performed, and peak pressure gradient, mean pressure gradient, indexed effective orifice area, and left ventricular mass index were measured. RESULTS: The follow-up rate in the 221 patients was 99.5% (maximum length, 24.1 years; mean, 10.3 years). Patients with a 19-mm valve were mainly women, older, and had smaller body surface areas. Freedom from valve-related death at 20 years was 100%, 86.0%, and 90.2% in patients with 19-, 21-, and 23-mm valves, respectively. There were no significant differences in the actuarial freedom from valve-related deaths. Echocardiography showed significantly higher peak (32.3 mm Hg) and mean pressure gradients (17.6 mm Hg) and a smaller indexed effective orifice area (0.70 +/- 0.15 cm(2)/m(2)) in patients with a 19-mm valve than in those with a 21- or 23-mm valve. Moderate prosthesis-patient mismatch was present in most patients with a 19-mm valve according to one definition; however, the improvements in ejection fraction and left ventricular mass index were significant, and functional recovery (mean New York Heart Association class, 1.3 +/- 0.5; mean specific activity scale, 5.1 +/- 0.8 metabolic equivalents) was satisfactory. CONCLUSIONS: The present long-term results demonstrate that a small St. Jude Medical valve can be advantageously used in most Japanese patients because their body size is generally smaller than that of Western patients. These findings also emphasize that it is not prosthesis size per se that matters but rather the relation between body size and prosthesis size.

Effect of surgery for atrial fibrillation associated with mitral valve disease.

BACKGROUND: The purpose of this study is to evaluate the effect of surgery for atrial fibrillation (AF) associated with mitral valve disease. METHODS: From September 1994 to December 2006, 244 patients who underwent mitral valve surgery were enrolled in this study. The maze procedure or pulmonary vein isolation was concomitantly performed in 147 patients, while the remaining 97 patients were not surgically treated for AF. The patients were divided into 3 groups based on their cardiac rhythm at discharge from the hospital: the sinus group (108 patients), the intractable AF group (39 patients), and the untreated AF group (97 patients). The clinical features and late results of patients were compared among these groups. RESULTS: Early mortality rate was 0.7% and no major morbid events had occurred. Follow-up was completed in 95.6% of the patients and the mean follow-up period was 6.03 years. Actuarial survival was not significant between the sinus and AF groups. Actuarial freedom from thromboembolism at 5 and 10 years was 96.5% in the sinus group, 82.4% and 78.1%, respectively, in the intractable AF group, and 93.4% and 89.1%, respectively, in the untreated AF group; statistical significance was observed among the 3 groups (p = 0.01). By means of multivariate analysis, intractable AF was found to be the only risk factor for thromboembolism and other complications. CONCLUSIONS: Atrial fibrillation associated with mitral valve disease should be treated, because restoration of the sinus rhythm might lead to a lower incidence of thromboembolism and valve-related complications in the later period.

Aortic root replacement in Behçet disease.

The patient presented with a history of recurrent aphthous stomatitis, genital ulceration, and a family history of positive for collagen disease. Echocardiography and retrograde aortography revealed aneurysm formation of the sinus of Valsalva, and dilatation of the aortic valve annulus with severe aortic regurgitation. On diagnosis of an aneurysm of the sinus of Valsalva and aortic regurgitation associated with Behçet's disease, aortic root replacement with the modified Bentall technique was successfully performed.

Double-orifice repair for left atrioventricular valve regurgitation in atrioventricular septal defect: report of two cases.

We describe two patients who successfully underwent a surgically created double-orifice repair using the edge-to-edge repair for residual left atrioventricular valve (LAVV) regurgitation in an atrioventricular septal defects (AVSD). Both patients had previously received patch closure of the AVSD and partial closure of a cleft of the LAVV. Preoperatively, echocardiography showed a wide open cleft and remarkable dilatation of the LAVV annulus. Doppler study revealed severe regurgitation through the cleft and the central portion of the LAVV orifice and no intracardiac shunt. Postoperative echocardiography showed a remarkable decrease of the AV valve regurgitation to none or trivial levels without stenosis of the LAVV in both patients. Among several valve-sparing techniques, our experience suggests that the surgically created double-orifice repair is one of the most effective reparative procedures for LAVV regurgitation in AVSD.

In vivo recellularization of plain decellularized xenografts with specific cell characterization in the systemic circulation: histological and immunohistochemical study.

Decellularized biological scaffolds have been used for the tissue engineering of heart valves with good results in the pulmonary circulation. However, little information is available on the recellularization of plain decellularized biological scaffolds in the systemic circulation. The aim of this study was to determine whether plain decellularized xenografts (PDXs) can recellularize with specific cell characterization in the systemic circulation. The xenogenic aortic valved conduit grafts of rabbits were implanted in the abdominal aorta of dogs after decellularization. The grafts were explanted at 4, 12, or 24 weeks after implantation for histological, immunohistochemical examination, scanning electron microscope, and Western blot analysis. Although the valvular structures were completely lost after implantation, supravalvular conduits showed normal shapes and endothelialization. The PDXs were repopulated with basic vascular cell components in approximate natural proportions without immunological responses. The PDXs had been recellularized with specific cell characterization in the systemic circulation.

Infection management in a patient with a left ventricular assist device: a case report of long-term cefazolin sodium hydrate administration.

A 55-year-old woman suffered from a bloodstream infection (Staphylococcus aureus), which originated from pump inflow and outflow skin exits, from 4 months after a parocorporeal left ventricular assist device (LVAD) had been implanted. In addition to local irrigation, repeated administration of a weekly unit of cefazolin hydrate was temporarily effective, but fever frequently recurred. Because short-term antibiotic administration had limited effectiveness, a much longer-term course of cefazolin was begun at 14 months post-LVAD implantation and was planned to continue until future transplantation. Unfortunately, the patient died from a cerebral embolism at 19 months after LVAD implantation; long-term consecutive cefazolin administration had suppressed the infection for over 5 months without side effects. To treat intractable LVAD-associated bloodstream infection, long-term administration of a narrow-spectrum beta-lactam drug is an effective option.